IP Verse

Dual Antigen-Induced Bipartite Functional Complementation - EP2802607

The patent EP2802607 was granted to Julius Maximilians Universitt Wrzburg on Oct 4, 2017. The application was originally filed on Jan 14, 2013 under application number EP13704369A. The patent is currently recorded with a legal status of "Revoked".

EP2802607

JULIUS MAXIMILIANS UNIVERSITT WRZBURG
Application Number
EP13704369A
Filing Date
Jan 14, 2013
Status
Revoked
Jun 30, 2023
Grant Date
Oct 4, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

F HOFFMANN LA ROCHEJul 4, 2018BOULT WADE TENNANT -
REVITOPEJul 3, 2018POTTER CLARKSON -

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP1536005
DESCRIPTIONWO2004016782
DESCRIPTIONWO2007062466
INTERNATIONAL-SEARCH-REPORTEP1561759
INTERNATIONAL-SEARCH-REPORTEP2133093
INTERNATIONAL-SEARCH-REPORTWO2004042404
INTERNATIONAL-SEARCH-REPORTWO2007062466
INTERNATIONAL-SEARCH-REPORTWO2010022225
INTERNATIONAL-SEARCH-REPORTWO9315210
OPPOSITIONEP1536005
OPPOSITIONUS8076459
OPPOSITIONWO2007062466
OPPOSITIONWO9409131

Non-Patent Literature (NPL) Citations (67) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- AMIT, SCIENCE, (1986), vol. 233, pages 747 - 753-
DESCRIPTION- BARGOU, R. ET AL., SCIENCE, (2008), vol. 321, pages 974 - 977-
DESCRIPTION- BLUEMEL C; HAUSMANN S; FLUHR P; SRISKANDARAJAH M; STALLCUP WB; BAEUERLE PA; KUFER P., "Epitope distance to the target cell membrane and antigen size determine the potency of T cell-mediated lysis by BiTE antibodies specific for a large melanoma surface antigen", CANCER IMMUNOL IMMUNOTHER., (201008), vol. 59, no. 8, pages 1197 - 209, XP019842190-
DESCRIPTION- COLMAN, NATURE, (1987), vol. 326, pages 358 - 363-
DESCRIPTION- DOUGLAS MAGDE, PHYSICAL REVIEW LETTERS, (1972), vol. 29, no. 11, pages 705 - 708-
DESCRIPTION- "Gaussia princeps luciferase", CHOPRA A., Molecular Imaging and Contrast Agent Database (MICAD, NATIONAL LIBRARY OF MEDICINE-
DESCRIPTION- INOUE Y ET AL., "Gaussia luciferase for bioluminescence tumor monitoring in comparison with firefly luciferase", MOL IMAGING, (20110426), vol. 10, pages 377 - 85-
DESCRIPTION- KAIN ET AL., BIOTECHNIQUES, (1995), vol. 19, no. 4, pages 650 - 55-
DESCRIPTION- KERPPOLA TK., "Visualization of molecular interactions using bimolecular fluorescence complementation analysis: characteristics of protein fragment complementation", CHEM SOC REV., (2009), vol. 38, pages 2876 - 86-
DESCRIPTION- KREITMAN RJ, AAPS J., (20060818), vol. 8, no. 3, pages E532 - 51-
DESCRIPTION- LAW, INT IMMUNOL, (2002), vol. 14, pages 389 - 400-
DESCRIPTION- LINKE, R ET AL., "Catumaxomab: clinical development and future directions", MABS, (2010), vol. 2, pages 129 - 136-
DESCRIPTION- MACK, PROC NATL ACAD SCI, (1995), vol. 92, pages 7021 - 7025-
DESCRIPTION- MAETZEL, NAT CELL BIOL, (2009), vol. 11, pages 162 - 171-
DESCRIPTION- MUNZ, CANCER CELL INT, (2010), vol. 10, page 44-
DESCRIPTION- OSSENKOPPELE ET AL., "Review of the relevance of aberrant antigen expression by flow cytometry in myeloid neoplasms", BR J HAEMATOL, (2011), vol. 153, no. 4, pages 421 - 36-
DESCRIPTION- PASTAN I; HASSAN R; FITZGERALD DJ; KREITMAN RJ, "Immunotoxin treatment of cancer", ANNU. REV. MED., (2007), vol. 58, pages 221 - 37, XP009134786-
DESCRIPTION- PEZARD C; BERCHE P; MOCK M., "Contribution of individual toxin components to virulence of Bacillus anthracis", INFECT. IMMUN., (1991), vol. 59, no. 10, page 3472, XP000650053-
DESCRIPTION- PLUCKTHUN, IMMUNOTECH., (1997), vol. 3, pages 83 - 105-
DESCRIPTION- Protein'Protein Interactions: Methods and Applications, HUMANA PRESS, (20040323), vol. 261, page 1-
DESCRIPTION- REICHERT, DRUG DISCOV TODAY, (2012), vol. 17, pages 954 - 963-
DESCRIPTION- SANTOS EB ET AL., "Sensitive in vivo imaging of T cells using a membrane-bound Gaussia princeps luciferase", NAT MED., (20090215), vol. 15, no. 3, pages 338 - 44-
DESCRIPTION- "The Cancer Genome Anatomy Project: building a new information and technology platform for cancer research", STRAUSBERG RL., Molecular Pathology of Early Cancer, IOS PRESS, (1999), pages 365 - 370-
DESCRIPTION- UEDA, NAT BIOTECHNOL, (1996), vol. 14, pages 1714 - 1718-
DESCRIPTION- UEDA, NATURE BIOTECHNOLOGY, (1996), vol. 14, pages 1714 - 1718-
DESCRIPTION- VASSILOPOULOS A ET AL., "Identification and characterization of cancer initiating cells from BRCA1 related mammary tumours using markers for normal mammary stem cells", INT J BIOL SCI, (2008), vol. 4, pages 133 - 142-
DESCRIPTION- WORN, JMB, (2001), vol. 305, pages 989 - 1010-
DESCRIPTION- YOGANAND BALAGURUNATHAN, "Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancer", MOL CANCER THER, (2008), vol. 7, pages 3071 - 3080-
DESCRIPTION- ZHU, PROTEIN SCI., (1997), vol. 6, pages 781 - 8-
DESCRIPTION- ZHOU J; BELOV L; HUANG PY; SHIN JS; SOLOMON MJ; CHAPUIS PH; BOKEY L; CHAN C; CLARKE C; CLARKE SJ, "Surface antigen profiling of colorectal cancer using antibody microarrays with fluorescence multiplexing", J IMMUNOL METHODS, (2010), vol. 355, doi:doi:10.1016/j.jim.2010.01.015, pages 40 - 51, XP055054063
DESCRIPTION- GOLDENBERG DM; CHATAL JF; BARBET J; BOERMAN 0; SHARKEY RM., "Cancer Imaging and Therapy with Bispecific Antibody Pretargeting", UPDATE CANCER THER., (200703), vol. 2, no. 1, doi:doi:10.1016/j.uct.2007.04.003, pages 19 - 31, XP022153216
DESCRIPTION- ESSONO S; FROBERT Y; GRASSI J; CREMINO C; BOQUET D, "A general method allowing the design of oligonucleotide primers to amplify the variable regions from immunoglobulin cDNA", J IMMUNOL METHODS, (2003), vol. 279, doi:doi:10.1016/S0022-1759(03)00242-4, pages 251 - 266, XP004455324
DESCRIPTION- WANG Z; RAIFU M; HOWARD M; SMITH L; HANSEN D; GOLDSBY R; RATNER D, "Universal PCR amplification of mouse immunoglobulin gene variable regions: the design of degenerate primers and an assessment of the effect of DNA polymerase 3' to 5'exonuclease activity", J IMMUNOL METHODS, (2000), vol. 233, no. 1-2, doi:doi:10.1016/S0022-1759(99)00184-2, pages 167 - 177, XP004188255
DESCRIPTION- NAGAI T ET AL., "A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications", NAT BIOTECHNOL., (200201), vol. 20, no. 1, doi:doi:10.1038/nbt0102-87, pages 87 - 90, XP002218913
DESCRIPTION- VAN DAM GM ET AL., "Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-a targeting: first in-human results", NAT MED., (20110918), vol. 17, no. 10, doi:doi:10.1038/nm.2472, pages 1315 - 9, XP055299051
DESCRIPTION- REMY I; MICHNICK S, "A highly sensitive protein-protein interaction assay based on Gaussia luciferase", NATURE METHODS, (2006), vol. 3, doi:doi:10.1038/nmeth979, pages 977 - 979, XP009102125
DESCRIPTION- ORLANDI R; GUSSOW PT, "Cloning immunoglobulin variable domains for expression by the polymerase chain reaction", PROC NATL ACAD SCI USA, (1989), vol. 86, no. 10, doi:doi:10.1073/pnas.86.10.3833, pages 3833 - 3837, XP000026475
DESCRIPTION- BARRETT T ET AL., "NCBI GEO: archive for functional genomics data sets-10 years on", NUCLEIC ACIDS RES., (2011), vol. 39, doi:doi:10.1093/nar/gkq1184, pages D1005 - 10, XP055067018
DESCRIPTION- BARGOU R ET AL., "Tumor regression in cancer patients by very low doses of a T cell-engaging antibody", SCIENCE, (2008), vol. 321, no. 5891, doi:doi:10.1126/SCIENCE.1158545, pages 974 - 7, XP002615656
DESCRIPTION- NATASHA Y. FRANK; TOBIAS SCHATTON; MARKUS H. FRANK, "The therapeutic promise of the cancer stem cell concept", J CLIN INVEST., (2010), vol. 120, doi:doi:10.1172/JCI41004, pages 41 - 50, XP055212054
DESCRIPTION- TOPP MS ET AL., "Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival", J CLIN ONCOL., (2011), vol. 29, doi:doi:10.1200/JCO.2010.32.7270, pages 2493 - 8, XP055112754
DESCRIPTION- CARTER P; SMITH L; RYAN M., "Identification and validation of cell surface antigens for antibody targeting in oncology", ENDOCR RELAT CANCER, (2004), vol. 11, doi:doi:10.1677/erc.1.00766, pages 659 - 87, XP009078100
DESCRIPTION- MULLER; KONTERMANN, "Bispecific antibodies for cancer immunotherapy: Current perspectives", BIODRUGS, (2010), vol. 24, no. 2, doi:doi:10.2165/11530960-000000000-00000, pages 89 - 98, XP009164507
INTERNATIONAL-SEARCH-REPORT- BIOLINK PARTNERS LTD, "Demibodies: Dimerization-activated therapeutic antibodies", INTERNET CITATION, (2007), URL: http://www.biolink.org.au/library/File/Demibodies.pdf, (20070101), XP003013805 [Y] 1-46 * the whole document *-
INTERNATIONAL-SEARCH-REPORT- RHEINNECKER M ET AL, "Multivalent antibody fragments with high functional affinity for a tumor-associated carbohydrate antigen.", JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 1 OCT 1996 LNKD- PUBMED:8816407, (19961001), vol. 157, no. 7, ISSN 0022-1767, pages 2989 - 2997, XP002675911 [A] 1-46 * the whole document *-
INTERNATIONAL-SEARCH-REPORT- KAWASHIMA REI ET AL, "EpCAM- and EGFR-targeted selective gene therapy for biliary cancers using Z33-fiber-modified adenovirus.", INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER 1 SEP 2011, (20110901), vol. 129, no. 5, ISSN 1097-0215, pages 1244 - 1253, XP002699347 [Y] 1-46 * the whole document *
INTERNATIONAL-SEARCH-REPORT- KIMURA N ET AL, "2D7 diabody bound to the alpha2 domain of HLA class I efficiently induces caspase-independent cell death against malignant and activated lymphoid cells", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, (20041224), vol. 325, no. 4, doi:10.1016/J.BBRC.2004.10.163, ISSN 0006-291X, pages 1201 - 1209, XP004649732 [Y] 1-46 * the whole document *
INTERNATIONAL-SEARCH-REPORT- XIE Z ET AL, "A new format of bispecific antibody: highly efficient heterodimerization, expression and tumor cell lysis", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, (20050101), vol. 296, no. 1-2, doi:10.1016/J.JIM.2004.11.005, ISSN 0022-1759, pages 95 - 101, XP004738464 [A] 1-46 * the whole document *
INTERNATIONAL-SEARCH-REPORT- ZHAO ET AL, "Therapeutic applications of superantibodies", DRUG DISCOVERY TODAY, ELSEVIER, RAHWAY, NJ, US, (20050915), vol. 10, no. 18, doi:10.1016/S1359-6446(05)03530-0, ISSN 1359-6446, pages 1231 - 1236, XP005103828 [A] 1-46 * the whole document *
INTERNATIONAL-SEARCH-REPORT- OHIRO YOSHIYUKI ET AL, "A homogeneous and noncompetitive immunoassay based on the enhanced fluorescence resonance energy transfer by leucine zipper interaction", ANALYTICAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 74, no. 22, doi:10.1021/AC0203387, ISSN 0003-2700, (20021115), pages 5786 - 5792, (20021019), XP002605915 [Y] 1-46 * the whole document *
INTERNATIONAL-SEARCH-REPORT- HEUSER C ET AL, "An anti-MUC1-antibody-interleukin-2 fusion protein that activates resting NK cells to lysis of MUC1-positive tumour cells", BRITISH JOURNAL OF CANCER, HARCOURT PUBLISHERS, (20030101), vol. 89, no. 6, doi:10.1038/SJ.BJC.6601267, ISSN 0007-0920, pages 1130 - 1139, XP003013806 [A] 1-46 * the whole document *
INTERNATIONAL-SEARCH-REPORT- SEIFERT OLIVER ET AL, "The IgM CH2 domain as covalently linked homodimerization module for the generation of fusion proteins with dual specificity.", PROTEIN ENGINEERING, DESIGN & SELECTION : PEDS OCT 2012, (201210), vol. 25, no. 10, ISSN 1741-0134, pages 603 - 612, XP002699346 [YP] 1-46 * the whole document *
INTERNATIONAL-SEARCH-REPORT- VAN BEUSECHEM VICTOR W ET AL, "Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolished.", JOURNAL OF VIROLOGY MAR 2002, (200203), vol. 76, no. 6, ISSN 0022-538X, pages 2753 - 2762, XP002699348 [Y] 1-46 * the whole document *
INTERNATIONAL-SEARCH-REPORT- KIPRIYANOV S M ET AL, "Generation and production of engineered antibodies", MOLECULAR BIOTECHNOLOGY, HUMANA PRESS, INC, US, (20040101), vol. 26, no. 1, doi:10.1385/MB:26:1:39, ISSN 1073-6085, pages 39 - 60, XP009044299 [A] 1-46 * the whole document *
INTERNATIONAL-SEARCH-REPORT- MILLER KATHY ET AL, "Design, construction, and in vitro analyses of multivalent antibodies.", JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 1 MAY 2003 LNKD- PUBMED:12728922, (20030501), vol. 170, no. 9, ISSN 0022-1767, pages 4854 - 4861, XP002675910 [A] 1-46 * the whole document *
OPPOSITION- AGNES BANASZEK, "Dual Antigen-Restricted Complementation of a Two-Part Trispecific Antibody for Targeted lmmunotherapy of Blood Cancer", Dissertation, (20130900), XP055512112-
OPPOSITION- AGNES BANASZEK et al., "Abstract of a Short Communication presented at the 8 Fabisch-Symposium", Cancer Research and Molecular Cell Biology, (20120321), XP055512109-
OPPOSITION- HOCHMAN et al., "An Active Antibody Fragment (Fv) Composed of the Variable Portions of Heavy and Light Chains", Biochemistry, (19730000), vol. 12, no. 6, pages 1130 - 1135, XP055512115-
OPPOSITION- HORNE et al., "NONCOVALENT ASSOCIATION OF HEAVY AND LIGHT CHAINS OF HUMAN IMMUNOGLOBULINS", Journal of Immunology, (19820801), vol. 129, no. 2, pages 660 - 664, XP055512125-
OPPOSITION- Polymenis M. et al., "Domain Interactions and Antigen Binding of Recombinant Anti-Z-DNA Antibody Variable Domains", Journal of Immunology, (19950000), vol. 154, no. 5, pages 2198 - 2208, XP055512121-
OPPOSITION- ANTHONY et al., "PRODUCTION OF STABLE ANTI-DIGOXIN FV IN ESCHERICHIA-COLI", Molecular Immunology, (19920000), vol. 29, pages 1237 - 1247, XP002433796
OPPOSITION- HOCHMAN et al., "Folding and Interaction of Subunits at the Antibody Combining Site", Biochemistry, (19760000), vol. 15, no. 12, pages 2706 - 2710, XP055512118
OPPOSITION- WARD et al., "BINDING ACTIVITIES OF A REOPERTOIRE OF SINGLE IMMUNOGLOBULIN VARIABLE DOMAINS SECRETED FROM ESCHERICHIA COLI", Nature, (19890000), vol. 341, no. 6242, pages 544 - 546, XP000086104
OPPOSITION- UEDA et al., "OPEN SANDWICH ELISA: A NOVEL IMMUNOASSAY BASED ON THE INTERCHAIN INTERACTION OF ANTIBODY VARIABLE REGION", Nature Biotechnology, (19960000), vol. 14, pages 1714 - 1718, XP002085341
OPPOSITION- WANG et al., "A New Recombinant Single Chain Trispecific Antibody Recruits T Lymphocytes to Kill CEA (Carcinoma Embryonic Antigen) Positive Tumor Cells In Vitro Efficiently", J. Biochem., (20040000), vol. 135, no. 4, pages 555 - 565, XP055132180
OPPOSITION- MASUDA et al., "Loss or down-regulation of HLA class I expression at the allelic level in freshly isolated leukemic blasts", Cancer Sci., (20070000), vol. 98, no. 1, pages 102 - 108, XP055509323
OPPOSITION- JORDAN et al., "Evaluation of the potential use of hybrid LC-MS/MS for active drug quantification applying the 'free analyte QC concept'", Bioanalysis., (20170000), vol. 9, no. 21, pages 1705 - 1717, XP055512175

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents